Skeptic critique for analysis db9a224d-3ebb-429c-8f02-b703d71ca211: Non-Neuronal Transcriptional Changes Preceding Tau Propagation as Early AD Biomarkers
The source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal cell types in Alzheimer's disease could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: lipid droplet accumulation may be compensatory rather than causal, and bulk amyloid readouts can miss subpopulation-specific effects.
The debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing APOE ε4-driven microglial lipid handling in the disease-relevant model, even when technical power and cell-state annotation are adequate.
The strongest alternative explanation is that RNA-, APOE mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.